Literature DB >> 30675687

Comparing Techniques for Mesenteric Defects Closure in Laparoscopic Gastric Bypass Surgery-a Register-Based Cohort Study.

Erik Stenberg1, Johan Ottosson2, Eva Szabo2, Ingmar Näslund2.   

Abstract

BACKGROUND: Routine closure of mesenteric defects is generally considered standard part of laparoscopic gastric bypass surgery today. Controversy still exists regarding the optimal method for mesenteric defects closure. The objective was to compare different methods for mesenteric defects handling in laparoscopic gastric bypass surgery.
METHODS: Primary laparoscopic gastric bypass procedures from 2010 until 2015 reported to the Scandinavian Obesity Surgery Registry (SOReg), where the mesenteric defects closure method was identifiable, were included. Main outcome measures were serious postoperative complication within 30 days after surgery, and reoperation for small bowel obstruction within 5 years after surgery. Quality-of-life before and after surgery, duration of surgery, and risk factors for complication were also analyzed. Information on operation for small bowel obstruction was based on data from the SOReg, the Swedish National Patient Register and reviews of hospital charts.
RESULTS: In all, 34,707 patients were included. Serious postoperative complication occurred in 174 (2.9%) patients with sutures, in 592 (3.1%, adjusted p = 0.079) with clips, and 278 (3.1%; adjusted p = 0.658) in the non-closure group. Reoperation for small bowel obstruction within 5 years after surgery was lower with sutures (cumulative incidence 6.9%) and clips (cumulative incidence 7.3%; adjusted HR 1.16, 95% CI 1.02-1.32, p = 0.026), compared to non-closure (cumulative incidence 11.2%; adjusted HR 1.63, 95% CI 1.44-1.84, p < 0.0001).
CONCLUSION: Closure of the mesenteric defects using either non-absorbable metal clips or non-absorbable running sutures is a safe and effective measure to reduce the risk for small bowel obstruction after laparoscopic gastric bypass surgery. Sutures appear slightly more effective and should remain gold standard for mesenteric defects closure.

Entities:  

Keywords:  Bariatric surgery; Gastric bypass; Internal hernia; Postoperative complication; Prevention; Small bowel obstruction

Mesh:

Year:  2019        PMID: 30675687     DOI: 10.1007/s11695-018-03670-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  30 in total

1.  Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program.

Authors:  Matthew M Hutter; Sheldon Randall; Shukri F Khuri; William G Henderson; William M Abbott; Andrew L Warshaw
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Maternal and fetal deaths after gastric bypass surgery for morbid obesity.

Authors:  Kimberly A Moore; David W Ouyang; Edward E Whang
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

3.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

4.  Bariatric Surgery Worldwide 2013.

Authors:  L Angrisani; A Santonicola; P Iovino; G Formisano; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

5.  Tensile strength after closure of mesenteric gaps in laparoscopic gastric bypass: three techniques tested in a porcine model.

Authors:  Hedin Jacobsen; Jan Dalenbäck; Mikael Ekelund; Hjörtur Gislason; Jan L Hedenbro
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

6.  Small bowel obstruction after antecolic antegastric laparoscopic Roux-en-Y gastric bypass without division of small bowel mesentery: a single-centre, 7-year review.

Authors:  Mohamed Abasbassi; Hans Pottel; Bert Deylgat; Franky Vansteenkiste; Frank Van Rooy; Dirk Devriendt; Mathieu D'Hondt
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

7.  Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial.

Authors:  Erik Stenberg; Eva Szabo; Göran Ågren; Johan Ottosson; Richard Marsk; Hans Lönroth; Lars Boman; Anders Magnuson; Anders Thorell; Ingmar Näslund
Journal:  Lancet       Date:  2016-02-16       Impact factor: 79.321

8.  Outcomes of laparoscopic gastric bypass in a randomized clinical trial compared with a concurrent national database.

Authors:  E Stenberg; E Szabo; J Ottosson; I Näslund
Journal:  Br J Surg       Date:  2017-02-27       Impact factor: 6.939

9.  Internal hernias after laparoscopic Roux-en-Y gastric bypass: incidence, treatment and prevention.

Authors:  Kelvin D Higa; Tienchin Ho; Keith B Boone
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

10.  Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.

Authors:  Erik Stenberg; Eva Szabo; Göran Agren; Erik Näslund; Lars Boman; Ami Bylund; Jan Hedenbro; Anna Laurenius; Göran Lundegårdh; Hans Lönroth; Peter Möller; Magnus Sundbom; Johan Ottosson; Ingmar Näslund
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

View more
  2 in total

1.  Risk of Reopening of the Mesenteric Defects After Routine Closure in Laparoscopic Roux-en-Y Gastric Bypass: a Single-Centre Experience.

Authors:  Ioannis I Lazaridis; Thomas Köstler; Lukas Kübler; Urs Zingg; Tarik Delko
Journal:  Obes Surg       Date:  2022-06-27       Impact factor: 3.479

2.  Does the non-absorbable suture closure of the jejunal mesenteric defect reduce the incidence and severity of internal hernias after laparoscopic Roux-en-Y gastric bypass?

Authors:  Romano Schneider; Michaela Schulenburg; Marko Kraljević; Jennifer M Klasen; Thomas Peters; Bettina Wölnerhanssen; Ralph Peterli
Journal:  Langenbecks Arch Surg       Date:  2021-05-22       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.